lovastatin has been researched along with Pachyonychia Congenita in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gartner, U; McLean, WH; Smith, FJ; Zhao, Y | 1 |
1 other study(ies) available for lovastatin and Pachyonychia Congenita
| Article | Year |
|---|---|
Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita.
Topics: Anticholesteremic Agents; Cell Line; Down-Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Keratin-6; Lovastatin; Mevalonic Acid; Pachyonychia Congenita; Promoter Regions, Genetic; STAT1 Transcription Factor | 2011 |